Table of Contents
ISRN Dentistry
Volume 2011 (2011), Article ID 102047, 5 pages
http://dx.doi.org/10.5402/2011/102047
Research Article

Clinical Assessment of Nifedipine-Induced Gingival Overgrowth in a Group of Brazilian Patients

Department of Diagnosis and Oral Surgery, Dental School, UNESP, 14801-903 Araraquara, SP, Brazil

Received 4 April 2011; Accepted 4 May 2011

Academic Editors: C. P. Lin and K. Schenck

Copyright © 2011 Cliciane Portela Sousa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Matsumoto, I. Noji, Y. Akimoto, and A. Fuj II, “Comparative study of calcium-channel blockers on cell proliferation, DNA and collagen syntheses, and EGF receptors of cultured gingival fibroblasts derived from human nifedipine, nicardipine and nisoldipine responders,” Journal of Oral Science, vol. 43, no. 4, pp. 261–268, 2001. View at Google Scholar · View at Scopus
  2. A. Doufexi, M. Mina, and E. Ioannidou, “Gingival overgrowth in children: epidemiology, pathogenesis, and complications. A literature review,” Journal of Periodontology, vol. 76, no. 1, pp. 3–10, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. P. D. Henry, “Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem,” American Journal of Cardiology, vol. 46, no. 6, pp. 1047–1058, 1980. View at Google Scholar · View at Scopus
  4. R. T. Butler, K. L. Kalkwarf, and W. B. Kaldahl, “Drug-induced gingival hyperplasia: phenytoin, cyclosporine, and nifedipine,” Journal of the American Dental Association, vol. 114, no. 1, pp. 56–60, 1987. View at Google Scholar · View at Scopus
  5. S. Barclay, J. M. Thomason, J. R. Idle, and R. A. Seymour, “The incidence and severity of nifedipine-induced gingival overgrowth,” Journal of Clinical Periodontology, vol. 19, no. 5, pp. 311–314, 1992. View at Google Scholar · View at Scopus
  6. E. B. Nery, G. E. Robert, K. L. Kelvin, K. P. Vijay, and W. James, “Prevalence of nifedipine-induced gingival hyperplasia,” Journal of Periodontology, vol. 66, no. 7, pp. 572–578, 1995. View at Google Scholar
  7. R. A. Seymour, J. M. Thomason, and J. S. Ellis, “The pathogenesis of drug-induced gingival overgrowth,” Journal of Clinical Periodontology, vol. 23, no. 3, pp. 165–175, 1996. View at Google Scholar · View at Scopus
  8. R. A. Seymour, J. S. Ellis, and J. M. Thomason, “Risk factors for drug-induced gingival overgrowth,” Journal of Clinical Periodontology, vol. 27, no. 4, pp. 217–223, 2000. View at Google Scholar · View at Scopus
  9. N. G. King, R. Fullinfaw, T. J. Higgins, D. M. A. Francis, and D. Wiesenfeld, “Gingival hyperplasia in renal allograft recipients receiving cyclosporin A and calcium antagonists,” Journal of Clinical Periodontology, vol. 20, no. 4, pp. 286–293, 1993. View at Google Scholar · View at Scopus
  10. J. S. Ellis, A. S. Robin, G. S. James, R. Pauline, J. B. Tim, and J. M. Thomason, “Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study,” Journal of Periodontology, vol. 70, no. 1, pp. 63–67, 1999. View at Publisher · View at Google Scholar
  11. E. Inglés, J. A. Rossmann, and R. G. Caffesse, “New clinical index for drug-induced gingival overgrowth,” Quintessence International, vol. 30, no. 7, pp. 467–473, 1999. View at Google Scholar · View at Scopus
  12. J. Silness and H. Lőe, “Periodontal disease in pregnancy II. Correlation between oral hygiene and periodontal condition,” Acta Odontologica Scandinavica, vol. 22, pp. 747–749, 1964. View at Google Scholar · View at Scopus
  13. H. Lőe, “The gingival index, the plaque index and the retention index system,” Journal of Periodontology, vol. 38, no. 6, pp. 610–616, 1967. View at Google Scholar · View at Scopus
  14. H. Zar, Biostatistical Analysis, Pearson Prentice Hall, New Jersey, NJ, USA, 4th edition, 1999.
  15. M. Ayres and M. Ayres Jr., Bioestat 2.0—Aplicações Estatísticas nas Áreas das Ciências Médicas Biológicas e Médicas, 1st edition, 2000.
  16. O. P. Kimbal, “The treatment of epilepsy with sodium diphenylhydantoin,” Journal of the American Medical Association, vol. 112, pp. 1244–1245, 1939. View at Google Scholar
  17. S. Tavassoli, Y. Nermin, C. Feriha, C. Gürhan, and E. Kenan, “The clinical effects of nifedipine on periodontal status,” Journal of Periodontology, vol. 69, no. 2, pp. 108–112, 1998. View at Google Scholar · View at Scopus
  18. J. M. Thomason, S. A. Seymour, J. A. Ellis et al., “Iatrogenic gingival overgrowth in cardiac transplantation,” Journal of Periodontology, vol. 66, no. 8, pp. 742–746, 1995. View at Google Scholar · View at Scopus
  19. J. A. James, J. J. Marley, S. Jamal et al., “The calcium channel blocker used with cyclosporin has an effect on gingival overgrowth,” Journal of Clinical Periodontology, vol. 27, no. 2, pp. 109–115, 2000. View at Google Scholar · View at Scopus
  20. V. Margiotta, I. Pizzo, G. Pizzo, and A. Barbaro, “Cyclosporine and nifedipine-induced gingival overgrowth in renal transplant patients: correlations with periodontal and pharmacological parameters and HLA-antigens,” Journal of Oral Pathology and Medicine, vol. 25, no. 3, pp. 128–134, 1996. View at Google Scholar · View at Scopus
  21. G. N. Güncü, F. Çaǧlayan, A. Dinçel, A. Bozkurt, S. Özmen, and E. Karabulut, “Clinical and pharmacological variables as a risk factor for nifedipine-induced gingival overgrowth,” Australian Dental Journal, vol. 52, no. 4, pp. 295–299, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Sooriyamoorty, D. B. Gower, and B. M. Eley, “Androgen metabolism in gingival hyperplasia induced by nifedipine and cyclosporin,” Journal of Periodontal Research, vol. 25, no. 1, pp. 25–30, 1990. View at Google Scholar · View at Scopus
  23. J. Miranda, L. Brunet, P. Roset, L. Berini, M. Farré, and C. Mendieta, “Prevalence and risk of gingival enlargement in patients treated with nifedipine,” Journal of Periodontology, vol. 72, no. 5, pp. 605–611, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. R. B. Johnson, E. J. Zebrowski, and X. Dai, “Synergic enhancement of collagenous protein synthesis by human gingival fibroblasts exposed to nifedipine and interleucin-1-beta in vitro,” Journal of Pathology and Medicine, vol. 29, pp. 8–12, 2000. View at Google Scholar
  25. R. B. Johnson, “Sinergistic enhancement of colagenous protein synthesis by human gingival fibroblats exposed to nifedipine and TNF- alpha in vitro,” Journal of Pathology and Medicine, vol. 32, pp. 408–413, 2003. View at Google Scholar